Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dechra extends dermatology range with Osurnia®
Otitis externa is a common challenge for both vets and clients.
Product will support vets in the treatment of otitis externa.

Veterinary pharmaceuticals firm Dechra has announced the expansion of its range of products to treat otitis externa with the introduction of Osurnia ®.

The announcement follows Dechra’s acquisition of the worldwide rights to the marketing and manufacture of the product from Elanco Animal Health Inc.

 “We know that otitis externa is a common challenge for both vets and clients with ear infections among the most frequent reasons for dogs to be presented at the vet clinic so we are delighted with the addition of Osurnia, which extends our range of solutions for veterinarians to manage otitis,” said Roddy Webster, Dechra Country Manager for the UK and ROI.

“We are now able to offer the best treatment for the pet taking into consideration the veterinarian’s clinical preference and the owner’s lifestyle. Dechra’s experience in otitis will bring a lot of added value to otitis externa management for veterinarians.”

Osurnia is formulated for the treatment of otitis externa associated with susceptible strains of the bacteria Staphylococcus pseudintermedius or the yeast Malassezia pachydermatis. A dose is the same for all dogs, administered from a pre-measured single-dose tube.

Other products in Dechra’s dermatology range include Canaural® and Recicort® and a range of ear cleaners.  

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
New guidance for antibiotic use in rabbits

New best practice guidance on the responsible use of antibiotics in rabbits has been published by the BSAVA in collaboration with the Rabbit Welfare Association & Fund (RWA&F).

The guidance is free and has been produced to help veterinary practitioners select the most appropriate antibiotic for rabbits. It covers active substance, dose and route of administration all of which are crucial factors when treating rabbits owing to the risk of enterotoxaemia.

For more information and to access the guide, visit the BSAVALibrary.